Therapy of advanced squamous carcinoma of the lung: cyclophosphamide vesus "COMB"
- PMID: 71943
- DOI: 10.1002/1097-0142(197703)39:3<1026::aid-cncr2820390305>3.0.co;2-p
Therapy of advanced squamous carcinoma of the lung: cyclophosphamide vesus "COMB"
Abstract
The four-drug combination of cyclophosphamide, vincristine, methyl CCNU and bleomycin was compared to CTX alone in a prospective randomized trial. Only one of 20 patients treated with COMB and one of 27 patients treated with CTX achieved a partial response. CTX was associated with a significantly better survival than COMB among patients who were ambulatory at onset of therapy. Survival among non-ambulatory patients was similar with both regimens.